Truvian Health receives US FDA clearance for CBC on its TruVerus multi-modal blood testing system: San Diego Saturday, January 24, 2026, 16:00 Hrs [IST] Truvian Health, a diagnost ...
CorMedix's DefenCath drives revenues with strong adoption, but 2026 outlook signals slower growth, raising concerns over long ...
Our extensive research on the United States Anticoagulation Therapy (2024-2032) offers valuable insights for businesses. This comprehensive report delves into emerging trends, inv ...
The firm's benchtop TruVerus system can now run a total of 26 FDA-cleared assays in three modalities from a single blood collection tube.
FDA Clearance of CBC Marks a Defining Platform Milestone, Expanding TruVerus™ to 26 Cleared Assays and the First FDA ...
CRMD and MIRM are advancing niche therapies with strong launches, rising sales and strategic acquisitions shaping their ...
Asianet Newsable on MSN
Why is Cadrenal Therapeutics stock drawing retail attention today?
The company said VLX-1005 targets a high-risk heparin complication with limited treatment options.
A nurse has been suspended after being found to have a ‘lack of competence.’ Silpa Vijayan, a former nurse at Dorset County Hospital, was employed on the Trauma and Orthopaedics Ward first when the ...
Detailed price information for Cadrenal Therapeutics Inc (CVKD-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results